Indeed, Levy et al. specified that this inhibitory effect on ADCC was dependent of the direct interaction between HLA-E/β2m, overexpressed by tumor cells, and its specific inhibitory receptor, CD94/NKG2A (NK group 2 member A) expressed by NK cells (8). Here, KLRC1 is linked to neoplasm.